Commercial Services Healthcare Sector

InnovAge Holding

Market Cap: US$572.7m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

Advanced Medical Solutions Group

Market Cap: UK£423.2m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

OrthoPediatrics

Market Cap: US$567.0m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Butterfly Network

Market Cap: US$566.3m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

Community Health Systems

Market Cap: US$563.1m

Owns, leases, and operates general acute care hospitals in the United States.

Owens & Minor

Market Cap: US$559.3m

Operates as a healthcare solutions company worldwide.

Kura Oncology

Market Cap: US$552.3m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Regulus Therapeutics

Market Cap: US$550.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Stoke Therapeutics

Market Cap: US$548.7m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Elite Pharmaceuticals

Market Cap: US$544.8m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Enhabit

Market Cap: US$537.3m

Provides home health and hospice services in the United States.

Tyra Biosciences

Market Cap: US$530.7m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Axogen

Market Cap: US$526.9m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Eton Pharmaceuticals

Market Cap: US$525.6m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Relay Therapeutics

Market Cap: US$522.9m

Operates as a clinical-stage precision medicines company.

Auna

Market Cap: US$517.8m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Capricor Therapeutics

Market Cap: US$503.2m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Talkspace

Market Cap: US$501.9m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

REGENXBIO

Market Cap: US$501.6m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Amylyx Pharmaceuticals

Market Cap: US$492.1m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Upstream Bio

Market Cap: US$491.1m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Healius

Market Cap: AU$755.2m

Provides specialty diagnostic services to consumer and practitioners in Australia.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

CytoDyn

Market Cap: US$485.2m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Arvinas

Market Cap: US$484.7m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

LifeMD

Market Cap: US$483.6m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Definitive Healthcare

Market Cap: US$482.9m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Clarity Pharmaceuticals

Market Cap: AU$745.5m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Zenas BioPharma

Market Cap: US$480.3m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Botanix Pharmaceuticals

Market Cap: AU$742.5m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Castle Biosciences

Market Cap: US$476.4m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Altimmune

Market Cap: US$474.5m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Theravance Biopharma

Market Cap: US$472.5m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Claritev

Market Cap: US$472.1m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

Sana Biotechnology

Market Cap: US$471.4m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.